Concert Pharmaceuticals Shares Drop 6% After Public Offering Prices
marketwatch.com
news
2022-06-02 10:15:00

By Chris Wack Concert Pharmaceuticals Inc. shares were down 6% to $5.04 in premarket trading after the company said it priced an underwritten public offering of 10 million common shares at $4.75 a share. The stock closed Wednesday's session down 16%. The gross proceeds to Concert are expected to be $47.5 million. The company has granted the underwriters a 30-day option to purchase up to an additional 1.5 million shares at the public offering price, less underwriting discounts and commissions. All shares in the offering are being sold by Concert.
